Latest Innovations
The Latest Life Science Innovations Changing Patients Lives
Click the social share buttons below to keep your network up to date on the latest life science innovations changing patients lives.
Sign Up - Newsletter
Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry
The Latest on Life Science Innovations
The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of August 26, 2026, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are:
-
Moderna and Merck’s intismeran autogene, a personalized vaccine for melanoma, helped prevent the cancer from returning or spreading in a late-stage trial.
-
Takeda’s Orzeyful received FDA approval to treat adults with narcolepsy type 1 by addressing the underlying cause of the sleep disorder.
-
Moderna’s mFlusiva, the first mRNA-based flu vaccine approved in the U.S., received FDA approval for adults ages 50 and older.